4 Results for "

releas

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "releas" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B0283
CAS No.: 51037-30-0
Synonyms: K-9321
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-P1628
CAS No.: 124904-93-4
Target:  

GnRH Receptor

Research Areas:  

Metabolic Disease

Ganirelix is a competitive and selective gonadotropin releasing hormone (GnRH) antagonist. Ganirelix prevents endogenous GnRH from inducing luteinising hormone (LH) and follicle stimulating hormone relea .
loading...
    loading...
Cat. No.: HY-B0283A
CAS No.: 76958-97-9
Synonyms: K-9321 sodium
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

Acipimox (K-9321) sodium, a nicotinic acid analogue, is an antilipolytic compound. Acipimox sodium stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-B0283R
CAS No.: 51037-30-0
Synonyms: K-9321 (Standard)
Research Areas:  

Metabolic Disease

Acipimox (Standard) is the analytical standard of Acipimox. This product is intended for research and analytical applications. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...